A study published on Eurosurveillance has demonstrated that Spain’s influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections (ARI) and hospitalization, as vaccination was recommended for this age group at the national level for the first time.
Emmet Stephenson gives $150M to City of Hope for pancreatic cancer, creating million-dollar research prize
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
September 18, 2024